We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.7B
AUM Growth
+$1.52B
Cap. Flow
+$861M
Cap. Flow %
2.55%
Top 10 Hldgs %
14.52%
Holding
3,141
New
144
Increased
1,491
Reduced
1,301
Closed
155

Sector Composition

Rank Sector Weight
1 Healthcare 14.29%
2 Financials 14.18%
3 Technology 13.8%
4 Industrials 10.4%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANTH
2801
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$174K ﹤0.01%
7,049
+2,267
+47% +$64K
CBMG
2802
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$173K ﹤0.01%
+14,394
New +$231K
TTGT icon
2803
TechTarget
TTGT
$325M
$171K ﹤0.01%
21,113
-4,690
-18% -$36.8K
MCBC
2804
DELISTED
Macatawa Bank Corp
MCBC
$171K ﹤0.01%
+23,031
New +$160K
CAI
2805
DELISTED
CAI International, Inc.
CAI
$171K ﹤0.01%
22,835
-8,685
-28% -$73.6K
ESPR
2806
DELISTED
Esperion Therapeutics
ESPR
$170K ﹤0.01%
17,186
+3,657
+27% +$60.6K
WATT icon
2807
Energous
WATT
$77.6M
$170K ﹤0.01%
+22
New +$143K
HCCI
2808
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$169K ﹤0.01%
13,812
-3,940
-22% -$44.1K
SRNE
2809
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$168K ﹤0.01%
29,975
+575
+2% +$3.67K
ZVO
2810
DELISTED
Zovio Inc. Common Stock
ZVO
$168K ﹤0.01%
23,225
-4,919
-17% -$42.1K
ASC icon
2811
Ardmore Shipping
ASC
$710M
$167K ﹤0.01%
24,602
-1,304
-5% -$11.4K
CETV
2812
DELISTED
Central European Media Enterprises Ltd
CETV
$167K ﹤0.01%
78,915
-8,657
-10% -$21.5K
LAYN
2813
DELISTED
Layne Christensen Co
LAYN
$165K ﹤0.01%
+20,364
New +$166K
EMKR
2814
DELISTED
Emcore Corp
EMKR
$165K ﹤0.01%
2,777
-496
-15% -$28K
NIHD
2815
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$165K ﹤0.01%
+51,921
New +$218K
TNAV
2816
DELISTED
Telenav Inc.
TNAV
$163K ﹤0.01%
31,899
-9,680
-23% -$50.5K
LMAT icon
2817
LeMaitre Vascular
LMAT
$2.32B
$161K ﹤0.01%
11,252
-2,321
-17% -$35.5K
ATHX
2818
DELISTED
Athersys, Inc. Common Stock
ATHX
$161K ﹤0.01%
+2,975
New +$169K
NERV icon
2819
Minerva Neurosciences
NERV
$185M
$160K ﹤0.01%
+1,955
New +$124K
ZAGG
2820
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$160K ﹤0.01%
30,540
+3,060
+11% +$20.1K
TVRD
2821
Tvardi Therapeutics
TVRD
$19.7M
$159K ﹤0.01%
917
+388
+73% +$84.5K
PLPM
2822
DELISTED
Planet Payment, Inc
PLPM
$159K ﹤0.01%
+35,454
New +$145K
AGTC
2823
DELISTED
Applied Genetic Technologies Corporation
AGTC
$156K ﹤0.01%
+11,067
New +$173K
STS
2824
DELISTED
Supreme Industries Inc Class A
STS
$155K ﹤0.01%
+11,297
New +$137K
DRRX
2825
DELISTED
DURECT Corp
DRRX
$153K ﹤0.01%
12,532
-601
-5% -$7.71K

Similar funds

RhumbLine Advisers's Q2 2016 Portfolio in Review

As of Q2 2016, RhumbLine Advisers held 3,141 positions worth $33.7B, up 4.7% from $32.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers's Q2 2016 filing shows 144 new, 1,491 increased, 1,301 reduced and 155 closed positions. Its largest new stake was S&P Global: 401,386 shares worth $43.1M. The largest sale was TIME WARNER CABLE INC NEW COM STK, an estimated $86.8M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Financials and Technology.

  • RhumbLine Advisers's largest Q2 2016 buy was S&P Global: 401,386 shares worth $43.1M.
  • RhumbLine Advisers added most to ExxonMobil in Q2 2016, an estimated $33.4M increase.
  • RhumbLine Advisers's biggest Q2 2016 reduction was Coca-Cola Europacific Partners, cutting an estimated $16.1M.
  • RhumbLine Advisers fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $86.8M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $33.7B portfolio in Q2 2016.
  • RhumbLine Advisers opened 144 new positions and closed 155 in Q2 2016.
  • RhumbLine Advisers's portfolio value rose 4.7% quarter-over-quarter to $33.7B.

Based on RhumbLine Advisers's 13F filing for Q2 2016, filed 11 Aug 2016.